[{"id":"23643ccd-1224-410a-86ab-8453a562d715","acronym":"CRUKD/12/004","url":"https://clinicaltrials.gov/study/NCT01791595","created_at":"2021-01-18T07:56:09.533Z","updated_at":"2025-02-25T15:05:29.958Z","phase":"Phase 1","brief_title":"A Phase I Trial of AZD3965 in Patients With Advanced Cancer","source_id_and_acronym":"NCT01791595 - CRUKD/12/004","lead_sponsor":"Cancer Research UK","biomarkers":" SLC16A1","pipe":"","alterations":" ","tags":["SLC16A1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AZD-3965"],"overall_status":"Completed","enrollment":" Enrollment 53","initiation":"Initiation: 04/23/2013","start_date":" 04/23/2013","primary_txt":" Primary completion: 11/17/2020","primary_completion_date":" 11/17/2020","study_txt":" Completion: 11/17/2020","study_completion_date":" 11/17/2020","last_update_posted":"2022-04-11"}]